When No More Kids with Cancer was founded, the hope was that cures were around the corner. The reality is that cancer is difficult, very personalized, and science and technology are only recently advancing at a pace that can create breakthroughs.
We at No More Kids with Cancer believe we are on the cusp of breakthroughs. Thanks to your support, we've funded impactful research projects and trials. Our Pediatric Brain Cancer clinical trial is even moving to phase II, which is a huge step in cancer research. This treatment provides another step towards treating childhood brain cancer, and was not an option as recently as 2017. Whether it's the brain cancer trial or another project, strong research eventually leads to breakthroughs, and breakthroughs save lives.
Changing childhood cancer is a series of small wins that lead to big changes. It takes patience and requires persistent support. Your support is helping us achieve our goals an make an impact on childhood cancer.
No More Kids with Cancer awarded CHOP a $220,000 grant that will be directed to a Phase 1 clinical trial investigating the effectiveness of immune system cells called CAR T cells - to treat relapsed or refractory acute myeloid leukemia (AML) in children and young adults. The trial will test the safety and potential efficacy of a new CAR T - cell immunotherapy in children and young adults with AML - the second most common form of leukemia in children.
$155,000 award to UCSF's Pacific Pediatric Neuro-Oncology Consortium (PNOC) to support a Phase 1 clinical trial to determine the effectiveness of an engineered measles virus to kill medulloblastoma - a common form of childhood brain cancer. This form of treatment seeks to use the virus to infect and destroy cancer cells while leaving normal cells intact. Sabine Mueller, M.D., Ph.D. is the principal investigator. Trial update - the trial is enrolling patients in 4 hospitals so far, and is expected to be available in up to 15 hospitals in 2018. The results are "intriguing: and the trial is expected to go to Phase II within the next year.
No More Kids with Cancer awarded CHOP a $220,000 grant that will be directed to a Phase 1 clinical trial investigating the effectiveness of immune system cells called CAR T cells - to treat relapsed or refractory acute myeloid leukemia (AML) in children and young adults. The trial will test the safety and potential efficacy of a new CAR T - cell immunotherapy in children and young adults with AML - the second most common form of leukemia in children.
We support projects that promote cross-institutional sharing. The following hospitals have access to research and trials we fund:
The No More Kids with Cancer #MustardChallenge campaign raised awareness and funds for new treatments. The campaign shed light on the antiquated and toxic rugs used to treat children with cancer. Over 8 million people engaged with the message that "1950s Drugs are Unacceptable" for kids. The campaign was covered nationally, by over 40 news outlets.
The Mustard Challenge raised about $100,000 to support a Pediatric Brain Cancer Dream Team. A Dream Team is a cross-institution, cross-discipline team with a focus on accelerating new, groundbreaking discoveries in cancer treatments which can save lives today. You can learn more at www.mustardchallenge.com.
